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The capacity of low-dose ultraviolet B (UVB) radiation to 
disrupt epidermal Langerhans cell function and to prevent 
the induction of contact hypersensitivity (CH) is genetically 
determined in mice and men. In mice, TnJa and Lps are the 
genetic loci at which reside alleles that dictate susceptibility 
and resistance to the deleterious effect of UVB radiation. 
Detection of the UVB-susceptibility (UVB-S) and UVB-re-
sistance (UVB-R) traits relies upon the in vivo end point of 
contact hypersensitivity, and is cumbersome, labor intensive, 
and time consuming. It has recently been reported that 
hapten-immune murine T cells can secrete interleukin-3 
(IL-3) in vitro when exposed to hapten-derivatized syngeneic 
stimulator cells. To determine whether this assay might be 
useful in distinguishing UVB-R from UVB-S mice, panels 
of UVB-susceptible (C57BL/IO, C3H/HeN) and UVB-
resistant (A/], BALB/c, C3H/He]) mice were sensitized 
epicutaneously with dinitrofluorobenzene (DNFB). When 
Acute, low-dose ultraviolet B (UVB) irradiation (400 ] / m2 X 4 d) of body wall skin depletes the epider-mis profoundly ofIa+ Langerhans cells in all strains of laboratory mice [1]. However, this same UVB regi-men impairs the induction of contact hypersensitivity 
(CH) to dinitrofluorobenzene (DNFB) fainted on irradiated skin 
only in some (not all) strains of mice [2,3 . Mice that fail to develop 
CH when D NFB is painted on UVB-treated skin also become toler-
ant, because they are unable subsequently to develop CH when an 
immunizing dose of hapten is painted on unirradiated skin [2]. 
Strains of mice that fail to develop CH when hapten is painted on 
UVB-treated skin are termed "UVB susceptible" (UVB-S), where-
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ONCE: dinitrochlorobe112ene 
DNFE: dinitrofluorobenzene 
IL-3: interleukin-3 
TNCE: trinitrochlorobenzene 
TNFa: tumor necrosis factor-alpha 
UVE: ultraviolet E light 
UVE-R: UVE resistant 
UES-S: UVE susceptible 
challenged in vitro 6 d later with dinitrophenyl-derivatized 
stimulator cells, T cells from all strains proliferated and se-
creted IL-3 . Moreover, T cells from UVB-R mice that were 
sensitized through UVB-treated skin also made copious 
amounts ofIL-3. However, T cells from UVB-S mice whose 
abdominal skin had been UVB irradiated prior to epicu-
taneous application of DNFB failed to secrete IL-3 in vitro, 
although the cells did proliferate. We conclude that follow-
ing application of a sensitizing dose of hapten to UVB-ex-
posed skin ofUVB-S mice a) hapten-specific T cells are selec-
tively unable to secrete IL-3 in vitro in response to hapten 
stimulation, and b) this inability is a r:eliable marker of the 
UVB-S trait. The IL-3 assay may prove useful in elucidating 
the mechanism by which UVB-exposed Langerhans cells 
activate regulatory T cells, and in detecting the UVB-S and 
UVB-R traits in humans.] Invest Dermatol 99:74S- 76S, 1992 
as strains of mice that develop CH, even when hapten is painted on 
UVB-exposed skin, are termed "UVB resistant" (UVB-R) [4]. 
GENETIC BASIS FOR UVB SUSCEPTIBILITY 
AND UVB RESISTANCE 
The c~paci~ of the acute, low-dose regimen of UVB to impair CH 
mductlOn IS genetically determmed, as revealed by studies con-
ducted i~ numerou.s inbred strains of mice ([3,4] and unpublished 
observations). Strams that have proved to be UVB-S include 
C57BL/l0; C57BL/6; C3H/HeN; S]L; SWR; PI]; the H-2-
congenic strains Bl0.BR, Bl0.S, Bl0.Q, and Bl0.M; and the LPS-
congenic strain, B6Smn.C3H-Lpsd. Strains that have been found to 
be UVB-R include BALB/c, DBA/2, A/], C3H/HeJ, and the 
H-2-congenic strains Bl0.A and B 10 .. D2. Based on these findings, 
it is apparent that the loci that govern the effects oflow-dose UVB 
on CH induction are a) Lps (where Lpsn confers the UVB-S pheno-
type and Lpsd confers the UVB-R phenotype), and b) H-2, the mur-
ine major histocompatibility complex. 
Analysis of the effects of UVB on induction of CH in critical H-2 
recombinant strains has made it possible to identify the locus within 
H-2 that is responsible for determining the alternative phenotypes 
of UVB-S and UVB-R. On the one hand, strains B10.A, A.TH, 
BI0.T(6R), and Bl0.D2(Rl06) are UVB-R, whereas on the other 
hand, strains BlO.S, A.SW, B10.A(2R), and NOD are UVB-S. This 
pattern of responses permits the conclusion that TnJa is the relevant 
intra-MHC locus. Strains that possess the TnJaJ allele are uniformly 
UVB-R, whereas all other strains possessing the alleles TnJak,b,.,qJ.p 
are UVB-S. 
In separate studies using F1 hybrids derived from various UVB-S 
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and/or UVB-R parents, it was determin~d tha~ UV~-S is a.dom~­
nant trait, and that UVB-S only occurs If the Irradiated ammal IS 
homozygous for a UVB-S allele at one locus (Trifa or Lps) , and also 
possesses a UVB-S allele in heterozygous or homozygous form at 
the other locus. 
Thus, the phenotype of UVB-S in mice is genetically deter-
rnined, acts as a ~o~inant trait, and is po~ygenically determined. 
Current evidence Illdlcates that polymorplusms at the Lps and Tnfa 
loci are sufficient to account for the phenotypes of UVB-S and 
UVB-R. Recent studies from our l.aboratory have r~vealed .that 
tumor necrosis factor-alpha (TN Fa) IS the major cytokllle mediator 
of the deleterious effe~ts of UVB on C:H induction [4,5]. Th~s, the 
genetic evidence that llllks polymorphlsms at Tnfa and Lps With the 
effects of UVB on CH induction supports the view that UVB-in-
duced release of TN Fa in the epidermis is responsible for impaired 
CH induction in UVB-S mice. 
EFFECTS OF UVB ON INDUCTION OF CONTACT 
HYPERSENSITIVITY IN HUMANS 
The study of CH in mice is believed to be an experimental model 
system of cutaneous immunity that is pertinent to the role of the 
immune system in the pathogenesis of skin tumors. Moreover, the 
deleterious effects of UVB radiation on experimental cutaneous 
immunity and CH, combined with the strong epidemiologic links 
between chronic sun exposure in humans and development of basal 
and squamous cell skin cancers, further strengthens this belief. Re-
cently, we have conducted a study in human volunteers to deter-
mine whether acute, low-dose UVB radiation is capable of impair-
ing CH induction in humans, as it does in selected strains of mice 
[6]. A UVB radiation protocol, similar to that used in mice, was 
delivered to buttock skin, after which a universally sensitizing dose 
(2000 J.lg) of dinitrochlorobenzene (DNCB) was applied. All sub-
jects were challenged with 50 J.lg DNCB on volar forearm skin 30 d 
thereafter to determine whether CH was induced. To summarize 
the results of experiments, which have been reported in detail else-
where, approximately 55% of healthy adult Caucasian subjects de-
veloped CH when DNCB was painted on UVB-treated skin, 
whereas the remainder (45%) failed to display CH. The former 
individuals have been designated UVB-R, whereas the latter have 
been designated UVB-S. It is of particular interest that, when a 
similar study was carried out in patients with biopsy-proved basal 
and/or squamous cell carcinoma (who were disease-free at the time 
of the study), a very high proportion (> 90%) turned out to be 
UVB-S. This result suggests that the UVB-S trait may be a signifi-
cant risk factor for sunlight-induced skin cancer in humans. In that 
study approximately 50% of skin cancer p~tients developed hapte.n-
specific tolerance when DNCB was applied to UVB-treated skill. 
By contrast, only 10% of UVB-S healthy volu~te~rs .d.ev~loped 
hapten-specific tolerance. Thus, there are many Similarities III the 
effects of UVB radiation on CH induction and tolerance induction 
by epicutaneous haptens in humans and in mice. 
DEVELOPMENT OF IN VITRO ASSAY OF UVB 
SUSCEPTIBILITY AND UVB RESISTANCE 
It is important to determine whether UVB-S and UVB-R are geneti-
cally determined traits in humans, an~ it is i~p~rtant to extend the 
studies of the effects of UVB on CH Illductlon III humans to other 
forms of skin cancer. Yet, in order to pursue these experimental 
issues, the process of identifying the UVB-S and UVB-R traits in 
humans needs to be simplified. In its current form, the protocol for 
detecting the UVB-S and UVB-R traits in humans requires an in-
terval 005 d and a maximum of95 d during which multiple inter-
actions between the investigator and the test subject take place [6]. 
We have therefore begun to search for an in vitro assay that would 
be less time and labor intensive. To that end, Marcinkiewicz and 
Chain have recently reported [7] that lymph nodes cells from mice 
sensitized epicutaneously with trinitrochlorobenzene (TNCB) 
contained hapten-specific T cells that secreted IL-2 and IL-3 when 
exposed in vitro to hapten-bearing syngeneic stimulator cells. More-
over, if unresponsiveness was induced in mice by intravenous il~ec-
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Table I. Effect of UVB Radiation on In Vitro Response of 
Lymph Node Cells to Hapten-Modified Stimulators 
Proliferation IL-3 Production 
Strain Responders SI' ODb 
AjJ Immune ' 4.2 475 
Immune UVBd 2.5 500 
Naive 1.0 50 
C3HjHeJ Immune ND' 380 
Immune-UVB ND 410 
Naive ND 55 
BALBjc Immune NB 305 
Immune-UVB ND 255 
Naive ND 35 
C57BLj10 Immune 5.8 165 
Immune-UVB 2.7 30 
Naive 1.0 25 
• SI, stimulation index oPH-thymidine incorporation. 
bOO, optical density of MIT assay, of lymphocyte activation. 
, Immune, lymph node cells harvested from mice whose skin was painted 7 d previ-
ously with 125 Ilg ONFD. 
J Immune-UVB, animals that received ONFD on UVD-treated skin. 
'NO, not determined. 
tion of the soluble hapten, trinitrobenzene sulfonate, and the skin of 
the recipients was subsequently painted epicutaneously with 
TNCB, the draining lymph nodes were found to be deficient in T 
cells capable of secreting IL-2 or IL-3 when stimulated in vitro with 
TNP-derivatized stimulator cells. We wished to determine 
whether the T cells of UVB-S mice rendered unresponsive by 
DNFB painted on UVB-treated skin were deficient in secreting 
IL-3 in vitro. 
It was first necessary to determine whether in vitro assays could 
detect hapten-specific T cells from the lymph nodes ofUVB-S and 
UVB-R mice painted epicutaneously with DNFB. Panels of A/] 
(UVB-R) and C57BL/10 (UVB-S) mice received 125J.lg DNFB in 
acetone on shaved abdominal skin. Seven days later the draining 
lymph nodes (inguinal, axillary) were removed, and a single cell 
suspension prepared. These cells were used as responders (5 X 105/ 
well) in cultures to which syngeneic spleen cells, derivatized with 
DNFB, were added as stimulators (2 X 105/well). The conditions 
of derivatization of the stimulator cells follow: 10 J.ll of a solution of 
2% DNFB in acetone was added to spleen cells at a concentration of 
5 X 106 cells/ml. After 45 min incubation at room temperature, the 
cells were washed repeatedly with culture medium and used as 
stimulators. After 2 d of culture, 3H-thymidine was added and the 
amount of incorporation determined after an additional 24 h. In 
companion cultures, supernatants were collected after 72 h and as-
sayed for IL-3 content. Quantitative assessment ofIL-3 was detected 
by determining the extent to which the IL-3 -responsive cell line, 
DA-1, proliferated in the presence of supernatant fluid. The results 
are summarized in Table 1. Draining lymph node cells from A/] and 
C57BL/IO mice sensitized with DNFB proliferated in vitro, and 
secreted IL-3 when exposed to DNFB-derivatized syngeneic spleen 
cells. 
In the next experiments, panels ofuVB-R mice (A/], C3H/He], 
BALB/c) and UVB-S mice (C57BL/I0) were exposed to four daily 
doses of UVB radiation. Immediately thereafter the skin was 
painted with DNFB. Seven days later the draining lymph nodes 
were obtained and the lymphoid cells cultured with DNFB-deriva-
tized syngeneic spleen cells. Proliferation and IL-3 secretion were 
both assayed and the results are presented in Table 1. Although the 
magnitude of proliferation was reduced (compared to unirradiated 
positive controls) draining lymph node cells from all strains dis-
played 3H-thymidine incorporation. This was true for both UVB-S 
and UVB-R strains. By contrast, only the supernatants of cultures 
containing cells from UVB-irradiated UVB-R mice contained IL-3. 
Supernatants from cultures in which lymphoid cells from UVB-
irradiated C57BL/I0 donors were used as responders contained no 
detectable IL-3 activity . Thus, lymph nodes draining hapten-
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painted, UVB-treated sites of UVB-R mice contained DNFB-im-
mune T cells that secreted IL-3 when exposed to DNP-derivatized 
syngeneic stimulator cells in vitro. No such cells were detectable in 
ly~ph nodes of hapten-painted, UVB-treated UVB-susceptible 
mice. 
SUMMARY AND CONCLUSIONS 
Our findings indicate that DNFB applied epicutaneously to UVB-
treated body wall skin activates DNFB-specific lymphocytes that 
can be harvested from the draining lymph nodes. However, the cells 
obtained from UVB-S mice differ from those obtained from UVB-
R mice. When confronted by DNFB-derivatized stimulator cells in 
vitro, lymph node lymphocytes from UVB-R mice were capable of 
undergoing proliferation and of secreting IL-3. By contrast, lymph-
oid cells from UVB-S mice were able to proliferate, but failed to 
generate sufficient IL-3 to be detected in the culture supernatants. 
These distinctive patterns were found in three UVB-R strains (A/J, 
C3H/HeJ, BALB/c) and one UVB-S strain (C57BL/10). Thus, the 
capacity of lymphocytes from UVB and hapten-treated donors to 
secrete IL-3 in response to hapten-modified syngeneic stimulators 
appears to be a reliable marker of the UVB-R phenotype in mice. If 
these observations are confirmed in further studies, and extended to 
include other cytokines of interest, then this approach may offer a 
useful means of detecting the UVB-S and UVB-R traits in humans. 
The current findings are of interest to the process by which UVB 
radiation conspires with epicutaneous hapten application to prevent 
the full activation of hapten-specific effector T cells in UVB-S 
mice. Both g~netic and immunologic evidence points to TN Fa as 
the critical link between the epidermal effects of UVB and the 
unique lymphocytes found in the draining node. In one sense, the 
generation of lymphocytes capable of proliferating, but failing to 
secrete IL-3, in response to haptenated stimulator cells suggests that 
a form of lymphocyte anergy may have been induced. In another 
sense, the proliferative, hapten-specific lymphocytes in the nodes of 
UVB-S mice may represent suppressor cells that could participate in 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
the generation of hapten-specific tolerance following UVB radia-
tion. In fact, Marcinkiewicz and Chain [7] reported that lymph 
node cells from TNBS-tolerized mice were capable of suppressing 
IL-2 secretion by hapten-specific T cells harvested from conven-
tionally sensitized donors. It will be of interest to determine 
whether similar suppressor cells can be identified among lymph 
node cells harvested from UVB- and hapten-treated UVB-S mice. If 
that proves to be the case, then the study of cytokines secreted by 
hapten-immune T cells may also be applied to analysis of hapten-
specific tolerance in humans. 
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